Advertisement
Screener

Lucid Diagnostics Inc. (LUCD) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Lucid Diagnostics Inc. Cash Flow Breakdown

Cash flow breakdown shows where Lucid Diagnostics Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $46.48M went out.
  • Fiscal year ended 2025-12-31: from investing, $197.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $59.03M came in.
  • Fiscal year ended 2025-12-31: change in cash, $12.35M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew debtNew shares soldNot split outChange in cash
2025-12-31-$46.48M-$197.00K$17.00K$59.01M*$12.35M
2024-12-31-$44.14M-$646.00K$4.00K$48.24M*$3.46M
2023-12-31-$32.82M-$221.00K$29.46M*-$3.58M
2022-12-31-$29.68M-$4.11M$1.81M$804.00K*-$31.18M
2021-12-31-$17.67M-$862.00K$72.08M*$53.55M
2020-12-31-$5.63M$7.94M$5.00K-$2.36M*-$45.00K

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew debtStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$11.30M*-$21.00K*$0.00*$1.00K*$16.84M*
2026-03-31-$12.10M-$215.00K-$17.00K$210.00K$5.29M*-$6.83M
2025-12-31-$12.58M*-$51.00K*$2.00K*
2025-09-30-$10.89M*-$28.00K*$2.00K*$27.13M*
2025-06-30-$10.55M*-$25.00K*$0.00*$10.00K*$16.45M*
2025-03-31-$12.46M-$93.00K$0.00$141.00K$15.30M*$2.88M
2024-12-31-$9.87M*-$259.00K*$0.00*$18.00M*
2024-09-30-$10.18M*-$350.00K*$0.00*
2024-06-30-$11.48M*$0.00*$0.00*$11.63M*
2024-03-31-$12.61M-$37.00K$4.00K$18.52M*$5.87M
2023-12-31-$9.98M*-$175.00K*$5.00M*
2023-09-30-$8.78M*-$14.00K*
2023-06-30-$6.94M*-$15.00K*$0.00*
2023-03-31-$7.12M-$17.00K$284.00K$23.90M*$17.05M
2022-12-31-$4.26M*-$203.00K*$0.00*
2022-09-30-$6.35M*-$1.32M*$6.00K*$1.92M*
2022-06-30-$13.30M*-$2.44M*$501.00K*
2022-03-31-$5.78M-$148.00K$187.00K-$5.74M
2021-12-31-$9.88M*-$824.00K*$64.34M*
2021-09-30-$2.18M*-$28.00K*
2021-06-30-$2.29M*-$1.00K*$4.44M*
2021-03-31-$3.31M-$9.00K$3.30M*-$24.00K
2020-12-31-$1.68M*$2.52M*$1.00*-$916.58K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
KORU Medical Systems, Inc. (KRMD)United States$0.151B-106.78
Profound Medical Corp. (PROF)$0.206B-7.37
Neuronetics, Inc. (STIM)United States$0.216B-3.25
Apyx Medical Corp (APYX)United States$0.120B-21.85
PRO DEX INC (PDEX)United States$0.234B13.64
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
Microbot Medical Inc. (MBOT)$0.089B-7.97
LENSAR, Inc. (LNSR)United States$0.087B2.02
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17